Get Access to Anakinra in India

Anakinra is an FDA approved drug recommended for the treatment of rheumatoid arthritis. It not only provides symptomatic relief but also slows down the joint damage caused by RA. Anakinra is essentially the formation of amino acids or residues of such amino acids that act against interleukin-1. Interleukin-1 is another protein form that causes pain and swelling in the joints. Kineret is its trade or commercial name which is owned by Swedish Orphan Biovitrum. Anakinra in India is an option offered by the treating physicians and the patients are free to import and use.

Kineret is also indicated for the management of Neonatal-Onset Multisystem Inflammatory Disease (NOMID). In RA, it is used as a second line option. It is recommended for the patients who failed on a previous treatment with any disease-modifying antirheumatic drug (DMARD). In the treatment of macrophage activation syndrome (MAS), this drug is found to be effective. This medication is also given for Schnitzler's syndrome treatment in off label settings.

It is available as 100mg/0.67ml prefilled synergies. Commercially Kineret 100mg can be obtained in a pack of 28 injections. Anakinra was approved by the US FDA in 2001 and further granted EU approval in 2002. Even though it is prominently known as the Biopharmaceutical agent for the treatment of RA, its other indications make this a drug of choice in many settings.